Metal compounds against neglected tropical diseases
Many first-line treatments for neglected tropical diseases identified by the World Health
Organization (WHO) are limited by one or more of the following: the development of drug …
Organization (WHO) are limited by one or more of the following: the development of drug …
An exhaustive compilation on chemistry of triazolopyrimidine: A journey through decades
The triazolopyrimidine scaffold represents one of the privileged structure in chemistry, and
there has been an increase in number of studies utilizing this scaffold and its derivatives …
there has been an increase in number of studies utilizing this scaffold and its derivatives …
Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis
A Badirzadeh, M Heidari-Kharaji… - PLOS Neglected …, 2020 - journals.plos.org
Background Neglected parasitic diseases (NTDs) like cutaneous leishmaniasis (CL) have
caused high mortality and morbidity rate in developing countries. This disease is considered …
caused high mortality and morbidity rate in developing countries. This disease is considered …
Cytotoxic and antileishmanial effects of the monoterpene β-ocimene
JMS Sousa, TAL Nunes, RRL Rodrigues, JPA Sousa… - Pharmaceuticals, 2023 - mdpi.com
Leishmaniasis is a group of infectious-parasitic diseases with high mortality rates, and
endemic in many regions of the globe. The currently available drugs present serious …
endemic in many regions of the globe. The currently available drugs present serious …
Synthesis, structure and biological activity of nickel (II) complexes with mefenamato and nitrogen-donor ligands
X Totta, AA Papadopoulou, AG Hatzidimitriou… - Journal of inorganic …, 2015 - Elsevier
Six novel nickel (II) complexes with the non-steroidal anti-inflammatory drug mefenamic acid
(Hmef) with the nitrogen-donor heterocyclic ligands 2, 2′-bipyridine (bipy), 2, 2 …
(Hmef) with the nitrogen-donor heterocyclic ligands 2, 2′-bipyridine (bipy), 2, 2 …
The Anti-Leishmania amazonensis and Anti-Leishmania chagasi Action of Copper(II) and Silver(I) 1,10-Phenanthroline-5,6-dione Coordination Compounds
SSC Oliveira, VS Santos, M Devereux, M McCann… - Pathogens, 2023 - mdpi.com
Leishmaniasis is a neglected disease caused by protozoa belonging to the Leishmania
genus. Notably, the search for new, promising and potent anti-Leishmania compounds …
genus. Notably, the search for new, promising and potent anti-Leishmania compounds …
Nanoemulsions containing a synthetic chalcone as an alternative for treating cutaneous leshmaniasis: optimization using a full factorial design
CB de Mattos, DF Argenta, GL Melchiades… - International journal …, 2015 - Taylor & Francis
Nanoemulsions are drug delivery systems that may increase the penetration of lipophilic
compounds through the skin, enhancing their topical effect. Chalcones are compounds of …
compounds through the skin, enhancing their topical effect. Chalcones are compounds of …
Pyrimidines-based heterocyclic compounds: synthesis, cytoxicity evaluation and molecular docking
MA El-Atawy, NA Alshaye, N Elrubi, EA Hamed… - Molecules, 2022 - mdpi.com
A variety of structurally different pyrimidines were synthesized. Elemental analysis, FT-IR, 1H
NMR, and 13C NMR spectroscopy were used to confirm the chemical structures of all …
NMR, and 13C NMR spectroscopy were used to confirm the chemical structures of all …
In vitro anticancer activity of novel Co (II) and Ni (II) complexes of non-steroidal anti-inflammatory drug niflumic acid against human breast adenocarcinoma MCF-7 …
Herein, we report the synthesis, characterization and anticancer activity of six novel
complexes of non-steroidal anti-inflammatory drug niflumic acid with Co (II) and Ni (II). In …
complexes of non-steroidal anti-inflammatory drug niflumic acid with Co (II) and Ni (II). In …
Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis
AB Caballero, A Rodríguez-Diéguez, M Quirós… - European journal of …, 2014 - Elsevier
Leishmaniasis and Chagas disease remain a significant global problem. Current treatments
have serious disadvantage due to cost, toxicity, long therapy duration and resistance. In the …
have serious disadvantage due to cost, toxicity, long therapy duration and resistance. In the …